New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
Protein kinase casein kinase 2 (CK2) is a serine/threonine kinase with evidence of implication in growth dysregulation and apoptosis resistance, making it a relevant target for cancer therapy. Several CK2 inhibitors have been developed showing variable efficiency, emphasizing the need to expand the...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2010
|
| _version_ | 1797058161923850240 |
|---|---|
| author | López-Ramos, M Prudent, R Moucadel, V Sautel, C Barette, C Lafanechère, L Mouawad, L Grierson, D Schmidt, F Florent, J Filippakopoulos, P Bullock, A Knapp, S Reiser, J Cochet, C |
| author_facet | López-Ramos, M Prudent, R Moucadel, V Sautel, C Barette, C Lafanechère, L Mouawad, L Grierson, D Schmidt, F Florent, J Filippakopoulos, P Bullock, A Knapp, S Reiser, J Cochet, C |
| author_sort | López-Ramos, M |
| collection | OXFORD |
| description | Protein kinase casein kinase 2 (CK2) is a serine/threonine kinase with evidence of implication in growth dysregulation and apoptosis resistance, making it a relevant target for cancer therapy. Several CK2 inhibitors have been developed showing variable efficiency, emphasizing the need to expand the chemical diversity of those inhibitors. We report the identification and characterization of 2,8-difurandicarboxylic acid derivatives as a new class of nanomolar ATP-competitive inhibitors. Selectivity profiling pointed out proviral insertion Moloney virus kinases (Pim kinases) as the only other kinases that are significantly inhibited. By combining structure-activity relationship analysis with structural determination, we were able to determine the binding mode of these inhibitors for both kinases and to explain their strong inhibitory potency. Essential chemical features necessary for activity on both kinases were then identified. The described compounds are not cell permeable: however, they could provide a lead for developing novel inhibitors usable also in vivo. Given the similar but not redundant pathophysiological functions of CK2 and Pim family members, such inhibitors would provide new attractive leads for targeted cancer therapy. This work highlights that 2 functionally related kinases from different kinome branches display exquisite sensitivity to a common inhibitor. |
| first_indexed | 2024-03-06T19:46:39Z |
| format | Journal article |
| id | oxford-uuid:228498b5-335a-4878-8c34-b718b221f843 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:46:39Z |
| publishDate | 2010 |
| record_format | dspace |
| spelling | oxford-uuid:228498b5-335a-4878-8c34-b718b221f8432022-03-26T11:39:18ZNew potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:228498b5-335a-4878-8c34-b718b221f843EnglishSymplectic Elements at Oxford2010López-Ramos, MPrudent, RMoucadel, VSautel, CBarette, CLafanechère, LMouawad, LGrierson, DSchmidt, FFlorent, JFilippakopoulos, PBullock, AKnapp, SReiser, JCochet, CProtein kinase casein kinase 2 (CK2) is a serine/threonine kinase with evidence of implication in growth dysregulation and apoptosis resistance, making it a relevant target for cancer therapy. Several CK2 inhibitors have been developed showing variable efficiency, emphasizing the need to expand the chemical diversity of those inhibitors. We report the identification and characterization of 2,8-difurandicarboxylic acid derivatives as a new class of nanomolar ATP-competitive inhibitors. Selectivity profiling pointed out proviral insertion Moloney virus kinases (Pim kinases) as the only other kinases that are significantly inhibited. By combining structure-activity relationship analysis with structural determination, we were able to determine the binding mode of these inhibitors for both kinases and to explain their strong inhibitory potency. Essential chemical features necessary for activity on both kinases were then identified. The described compounds are not cell permeable: however, they could provide a lead for developing novel inhibitors usable also in vivo. Given the similar but not redundant pathophysiological functions of CK2 and Pim family members, such inhibitors would provide new attractive leads for targeted cancer therapy. This work highlights that 2 functionally related kinases from different kinome branches display exquisite sensitivity to a common inhibitor. |
| spellingShingle | López-Ramos, M Prudent, R Moucadel, V Sautel, C Barette, C Lafanechère, L Mouawad, L Grierson, D Schmidt, F Florent, J Filippakopoulos, P Bullock, A Knapp, S Reiser, J Cochet, C New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights. |
| title | New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights. |
| title_full | New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights. |
| title_fullStr | New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights. |
| title_full_unstemmed | New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights. |
| title_short | New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights. |
| title_sort | new potent dual inhibitors of ck2 and pim kinases discovery and structural insights |
| work_keys_str_mv | AT lopezramosm newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT prudentr newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT moucadelv newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT sautelc newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT barettec newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT lafanecherel newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT mouawadl newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT griersond newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT schmidtf newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT florentj newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT filippakopoulosp newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT bullocka newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT knapps newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT reiserj newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights AT cochetc newpotentdualinhibitorsofck2andpimkinasesdiscoveryandstructuralinsights |